CoChat

Rabbit antithymocyte globulin–induced serum sickness disease and human kidney graft survival

Open access
Couvrat-Desvergnes, Grégoire, Salama, Apolline, Le Berre, Ludmilla, Evanno, Gwénaëlle, Viklicky, Ondrej, Hruba, Petra, Vesely, Pavel, Guerif, Pierrick, Dejoie, Thomas, Rousse, Juliette, Nicot, Arnaud, Bach, Jean-Marie, Ang, Evelyn, Foucher, Yohann, Brouard, Sophie, Castagnet, Stéphanie, Giral, Magali, Harb, Jean, Perreault, Hélène, Charreau, Béatrice, Lorent, Marine, Soulillou, Jean-Paul · 2015 · Journal of Clinical Investigation
Cited by 49

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Rabbit-generated antithymocyte globulins (ATGs), which target human T cells, are widely used as immunosuppressive agents during treatment of kidney allograft recipients. However, ATGs can induce immune complex diseases, including serum sickness disease (SSD). Rabbit and human IgGs have various antigenic differences, including expression of the sialic acid Neu5Gc and α-1-3-Gal (Gal), which are not synthesized by human beings. Moreover, anti-Neu5Gc antibodies have been shown to preexist and be elicited by immunization in human subjects. This study aimed to assess the effect of SSD on long-term kidney allograft outcome and to compare the immunization status of grafted patients presenting with SSD following ATG induction treatment. METHODS: We analyzed data from a cohort of 889 first kidney graft recipients with ATG induction (86 with SSD [SSD(+)] and 803 without SSD [SSD(-)]) from the Données Informatisées et Validées en Transplantation data bank. Two subgroups of SSD(+) and SSD(-) patients that had received ATG induction treatment were then assessed for total anti-ATG, anti-Neu5Gc, and anti-Gal antibodies using ELISA assays on sera before and after transplantation. RESULTS: SSD was significantly associated with long-term graft loss (>10 years, P = 0.02). Moreover, SSD(+) patients exhibited significantly elevated titers of anti-ATG (P = 0.043) and anti-Neu5Gc (P = 0.007) IgGs in late post-graft samples compared with SSD(-) recipients. CONCLUSION: In conclusion, our data indicate that SSD is a major contributing factor of late graft loss following ATG induction and that anti-Neu5Gc antibodies increase over time in SSD(+) patients. FUNDING: This study was funded by Société d'Accélération du Transfert de Technologies Ouest Valorisation, the European FP7 "Translink" research program, the French National Agency of Research, Labex Transplantex, the Natural Science and Engineering Research Council of Canada, and the Canadian Foundation for Innovation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci82267

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 49

Metadata

Authors
Couvrat-Desvergnes, G., Salama, A., Le Berre, L., Evanno, G., Viklicky, O., Hruba, P., Vesely, P., Guerif, P., Dejoie, T., Rousse, J., Nicot, A., Bach, J.-M., Ang, E., Foucher, Y., Brouard, S., Castagnet, S., Giral, M., Harb, J., Perreault, H., Charreau, B., Lorent, M., & Soulillou, J.-P.
Venue
Journal of Clinical Investigation
Published
2015-11-09
Volume
125
Issue
12
Pages
4655-4665
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2096797731
Cited by
49
References
3
FWCI
3.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rabbit antithymocyte globulin–induced serum sickness disease and human kidney graft survival. https://app.cochat.ai/papers/10.1172/jci82267
The paper
Couvrat-Desvergnes, G., Salama, A., Le Berre, L., Evanno, G., Viklicky, O., Hruba, P., Vesely, P., Guerif, P., Dejoie, T., Rousse, J., Nicot, A., Bach, J.-M., Ang, E., Foucher, Y., Brouard, S., Castagnet, S., Giral, M., Harb, J., Perreault, H., . . . Soulillou, J.-P. (2015). Rabbit antithymocyte globulin–induced serum sickness disease and human kidney graft survival. Journal of Clinical Investigation. https://doi.org/10.1172/jci82267

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.